Clinical Trials Browser

Phase 2 × giredestrant × 30 days × Clear all

NCT04931342 2026-03-10

BOUQUET

Phase 2 Active not recruiting

Ovarian Neoplasms

NCT05708235 2026-03-05

MiRaDoR

Phase 2 Recruiting

Breast Neoplasms, Neoplasm, Residual

NCT05896566 2026-02-24

PREcoopERA

Phase 2 Completed

Breast Neoplasms